You are here

Lobe Sciences Ltd.

Lobe Sciences Ltd.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
LOBE
CSE Index: 
Currency: 

The Company is working to develop psychedelic compounds as therapeutics. Initially the Company will develop psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of these medications. The Company also owned acquired brands, intellectual property and leases office and production premises to a cannabis processor and retailer which were disposed of on March 5, 2021.

You are here

Lobe Sciences Ltd. (LOBE)

SEDAR Information

Company Info

Address
Suite 1400-1199 West Hastings Street
Vancouver, BC V6E 3T5
Canada
Phone
1-949-505-5623
Email
info@lobesciences.com
Website
http://www.lobesciences.com
Listing date
Friday, June 7, 2019

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
155,136,172
Reserved for Issuance: 
39,369,671

Company Officers

Philip J. Young, CEO
Brian Zasitko, CFO

Bulletins

09/06/2022

2022-0613 – Consolidation - Lobe Sciences Ltd. (LOBE)

le 9 juin/June 2022

Lobe Sciences Ltd. (the "Issuer") has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every six (6) pre-consolidated common shares.

As a result, the outstanding common shares of the Issuer will be reduced to approximately 38,230,000 common shares.

Advertisement

Publicité

Latest CSE News

Upcoming Events

The ESG Checklist for Public Companies

The ESG Checklist for Public Companies

Tuesday, May 30, 2023 - 12:00pm
Summit on Responsible Investment

Summit on Responsible Investment

Tuesday, June 27, 2023 -
9:00am to 7:00pm